Posted on 12/13/17
Proteostasis Therapeutics Proposes Public Offering of Common Stock
CAMBRIDGE, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (Nasdaq:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies . . .
Posted on 12/12/17
IQVIA and Pierre Fabre Pharmaceuticals Expand Relationship
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a company dedicated to using analytics and science to help healthcare stakeholders find better solutions for patients, . . .
Posted on 12/12/17
TetraGenetics Partners with LifeArc
BOSTON & LONDON--(BUSINESS WIRE)--TetraGenetics, a biopharmaceutical company developing novel therapeutics for autoimmune diseases and pain, today announced a partnership with LifeArc®, the UK-based medical research charity. . . .
Posted on 12/12/17
Intermountain Healthcare to Partner with Press Ganey
BOSTON--(BUSINESS WIRE)--Press Ganey announced today that it has entered into a multi-year strategic relationship with Intermountain Healthcare, a recognized leader in clinical quality improvement and efficient . . .
Posted on 12/12/17
Palleon Pharmaceuticals Signs Exclusive License Agreement with King’s College London
WALTHAM, Mass.--(BUSINESS WIRE)--Palleon Pharmaceuticals, a company focused on developing Glycoimmune Checkpoint Inhibitors to treat cancer, today announced an agreement with King’s College London to license intellectual . . .
Posted on 12/12/17
Peak Physical Therapy & Sports Performance Accepting Donations for Charities at All Four Clinics
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide comprehensive treatment in orthopedic, spine and sports medicine specialties, is . . .
Posted on 12/12/17
bluebird bio Stock Soars on Unprecedented Blood Cancer Study Results
What happenedShares of the clinical-stage biotech bluebird bio (NASDAQ:BLUE) rose by as much as 23.9% in pre-market trading today. The catalyst? The company reported that its . . .
Posted on 12/12/17
Acer Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
NEWTON, Mass., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious . . .
Posted on 12/11/17
Medigene Collaborates with RXi Pharmaceuticals
RXi Pharmaceuticals Corporation (NASDAQ: RXII) announced today that it has entered into a research collaboration with Medigene AG (MDG1, Frankfurt, Prime Standard, TecDAX) to explore potential . . .
Posted on 12/11/17
First Clinical Data for X4P-001-RD Demonstrated Promising Activity in Patients with WHIM Syndrome
Dose dependent increases in neutrophil and lymphocyte counts observed in all patients treated with X4P-001-RDPreliminary results reported at ASH Annual Meeting from the open-label Phase 2 . . .
Posted on 12/8/17
Will CVS Get the Chance to Buy Aetna?
In this Market Foolery podcast, host Chris Hill is joined by Industry Focus: Healthcare host, Kristine Harjes, to dig into CVS Health's (NYSE:CVS) offer to purchase . . .
Posted on 12/8/17
Alexion and Halozyme Enter License Agreement for ENHANZE Technology
NEW HAVEN, Conn. & SAN DIEGO--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Halozyme Therapeutics, Inc. (NASDAQ:HALO) announced today a collaboration and license agreement that enables Alexion to . . .
Posted on 12/8/17
Neon Therapeutics Announces Clinical Trial Collaboration with Merck
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Neon Therapeutics, a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced that it has entered a clinical trial collaboration with Merck (known as MSD . . .
Posted on 12/6/17
DaVita Medical Group to Join Optum
BOSTON & EL SEGUNDO, Calif.--(BUSINESS WIRE)--Optum, a leading health services company, and DaVita Medical Group, one of the nation’s leading independent medical groups and a subsidiary . . .
Posted on 12/6/17
Bicycle Therapeutics and Cancer Research UK Named Best Partnership Alliance of the Year at 2017 Scrip Awards
LONDON, CAMBRIDGE, England & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) product platform, . . .
Posted on 12/6/17
Charles River Adds ERS License to CRISPR/Cas9 Service Offering
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the expansion of its CRISPR/Cas9 service offering with the addition of a license from ERS . . .
Posted on 12/6/17
Cerveau Technologies Signs Research Agreement with VU Medical Center Amsterdam
BOSTON--(BUSINESS WIRE)--Cerveau Technologies Inc. today announced an agreement with VU Medical Center (VUmc) in Amsterdam, to support multiple projects over the next several years. These research . . .
Posted on 12/6/17
Aetna (AET) Aetna Agrees To Be Acquired By CVS Conference (Transcript)
Aetna, Inc. (NYSE:AET)Aetna agrees to be acquired by CVS Conference CallDecember 04, 2017 08:30 AM ETExecutivesMike McGuire - SVP, IR, CVS HealthMark Bertolini - Chairman and . . .
Posted on 12/6/17
Editas Medicine Announces Offering of Common Stock
CAMBRIDGE, Mass., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it intends to offer and sell . . .
Posted on 12/5/17
Sekisui Diagnostics Enters Strategic Alliance with Mesa Biotech
Sekisui Diagnostics and Mesa Biotech Inc. announce a strategic alliance, to distribute the Mesa Biotech POC molecular system for Flu A/Flu B. Sekisui Diagnostics will assume . . .
Posted on 12/5/17
Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BURLINGTON, Mass., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to three new employees for an . . .
Posted on 12/4/17
Applied BioMath Announces Collaboration with Syntimmune
Applied BioMath® (www.appliedbiomath.com), the industry leader in applying mechanistic modeling to drug research and development, today announced a collaboration with Syntimmune to provide semi-mechanistic pharmacokinetic and . . .
Posted on 12/4/17
Blue Oak and PsychoGenics Announce a Drug Discovery Partnership
BOSTON & PARAMUS, N.J.--(BUSINESS WIRE)--Blue Oak Pharmaceuticals, Inc. (Blue Oak) and PGI Drug Discovery LLC (PsychoGenics), today announced that they have entered into a partnership to . . .
Posted on 12/4/17
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that, on December . . .
Posted on 12/4/17
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
BOSTON, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline . . .
Boston
